Growth after organ transplantation

Area of Science:

• Pediatric Endocrinology
• Transplantation Medicine
• Growth Hormone Therapy

Background:

• Childhood growth is often impaired before and after organ transplantation, especially kidney and liver transplants.
• Steroids used for immunosuppression significantly contribute to short stature in transplant recipients.
• While some catch-up growth occurs post-renal transplant, it's often insufficient.

Purpose of the Study:

• To evaluate the efficacy and safety of growth hormone (GH) therapy in pediatric organ transplant recipients.
• To assess the impact of GH on linear growth in children post-renal and liver transplantation.
• To identify potential risks associated with GH use, such as acute rejection episodes.

Main Methods:

• Review of randomized controlled clinical trials on GH use in renal transplant patients.
• Analysis of existing data on GH efficacy in liver transplant patients.
• Assessment of the relationship between prior rejection history and GH treatment outcomes.

Main Results:

• GH therapy consistently demonstrates a beneficial effect on linear growth in renal transplant recipients.
• GH also appears effective in liver transplant patients, though data is limited.
• Patients with a history of frequent acute rejections may face an increased risk during GH treatment.

Conclusions:

• GH therapy is potentially safe and effective for stable renal transplant recipients without recent acute rejection.
• Further long-term studies are essential to confirm GH's safety and efficacy in both liver and renal transplant patients.
• Optimizing pre-transplant growth with GH and minimizing post-transplant steroid exposure are critical strategies for improving outcomes.